This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Koç Üniversitesi. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ibrahim Halil Kavakli: Innovator in Circadian Rhythm Research
Introduction
Ibrahim Halil Kavakli is a notable inventor based in Istanbul, Turkey. He has made significant contributions to the field of circadian rhythm research. His work focuses on developing innovative solutions for treating circadian rhythm diseases and disorders.
Latest Patents
Kavakli holds a patent for a compound titled "2-[2-({12,12-DIMETHYL-4-OXO-6-PHENYL-3,11-DIOXATRICYCLO[8.4.0.0,2,7]TETRADECA-1,5,7,9-TETRAEN-8-YL}OXY)ACETAMIDO]BENZAMIDE AND DERIVATIVES AS INHIBITOR OF CLOCK:BMAL1 INTERACTION FOR THE TREATMENT OF CIRCADIAN RHYTHM DISEASES AND DISORDERS." This patent represents his innovative approach to addressing complex health issues related to circadian rhythms. He has 1 patent to his name.
Career Highlights
Kavakli is affiliated with Koç Üniversitesi, where he conducts research and collaborates with other experts in the field. His academic background and research initiatives have positioned him as a key figure in the study of circadian rhythms.
Collaborations
He has worked alongside talented colleagues such as Yagmur Umay Doruk and Darya Yarparvar. Their collaborative efforts contribute to advancing research in their shared field of interest.
Conclusion
Ibrahim Halil Kavakli is a prominent inventor whose work in circadian rhythm research is paving the way for new treatments and understanding of related disorders. His contributions are significant in the ongoing quest to improve health outcomes related to circadian rhythms.